Foresite Capital Management II as of March 31, 2017
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 13 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 37.2 | $87M | 4.0M | 21.73 | |
| Aerie Pharmaceuticals | 30.6 | $71M | 1.6M | 45.35 | |
| Epizyme | 11.3 | $27M | 1.5M | 17.15 | |
| Alder Biopharmaceuticals | 8.5 | $20M | 956k | 20.80 | |
| Nanostring Technologies (NSTGQ) | 4.2 | $9.8M | 493k | 19.87 | |
| Dermira | 2.7 | $6.3M | 185k | 34.11 | |
| Nexvet Biopharma Pub Ltd Co ord | 1.5 | $3.4M | 877k | 3.89 | |
| Jounce Therapeutics | 1.1 | $2.6M | 120k | 21.99 | |
| Orexigen Therapeutics | 0.9 | $2.1M | 622k | 3.44 | |
| Zafgen | 0.9 | $2.1M | 450k | 4.66 | |
| Bellicum Pharma | 0.6 | $1.3M | 105k | 12.34 | |
| Acceleron Pharma | 0.2 | $527k | 20k | 26.47 | |
| Natera (NTRA) | 0.2 | $450k | 51k | 8.87 |
